A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26)
Public ClinicalTrials.gov record NCT02608476. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to determine the safety and efficacy of CB-03-01 cream, 1%, versus the vehicle cream applied twice daily for 12 weeks in subjects with facial acne vulgaris.
Study identification
- NCT ID
- NCT02608476
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 732 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 9 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 16, 2015 (Actual)
- Primary completion
- Feb 21, 2018 (Actual)
- Completion
- Feb 21, 2018 (Actual)
- Last update posted
- Nov 20, 2020
2015 – 2018
United States locations
- U.S. sites
- 12
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clear dermatology & Aesthetic Center | Scottsdale | Arizona | 85255 | — |
| Johnson Dermatology | Fort Smith | Arkansas | 72916 | — |
| Center for Dermatology and Laser Surgery | Sacramento | California | 95819 | — |
| Belleair Research Center | Pinellas Park | Florida | 33781 | — |
| Arlington Dermatology | Arlington Heights | Illinois | 60005 | — |
| Kansas City Dermatology, PA | Overland Park | Kansas | 66215 | — |
| Maryland Laser Skin and Vein Institute | Hunt Valley | Maryland | 21030 | — |
| Sadick Research Group, LLC | New York | New York | 10075 | — |
| Skin Specialty Dermatology | New York | New York | 10155 | — |
| Clinical Partners, LLC | Johnston | Rhode Island | 02919 | — |
| Texas Dermatology and Laser Specialists | San Antonio | Texas | 78218 | — |
| Progressive Clinical Research, PA | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02608476, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2020 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02608476 live on ClinicalTrials.gov.